Have you heard of GoodRx (ticker symbol: GDRX), a U.S. stock?
It is a company that operates a prescription drug price comparison app.
In this article, I would like to introduce the company’s financial results for the period from October to December 2020, which were announced on March 11, 2021.
October-December 2020 period
EPS is 8¢ vs. 6¢ forecast.
Net sales: $154 million vs. $148 million expected.
Sales growth rate was +35.5% YoY.
Net income was -$298 million.
Operating cash flow was $14.9 million, down 10% from the same period last year. Cash flow from operations was $14.9 million, down 10% from the same period last year, compared to $16.5 million in the same period last year.